|
PRRC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.661600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.372400E-01 |
| Normal-vs-Stage2 |
4.482000E-01 |
| Normal-vs-Stage3 |
8.190200E-01 |
| Normal-vs-Stage4 |
6.063200E-01 |
| Stage1-vs-Stage2 |
6.231800E-01 |
| Stage1-vs-Stage3 |
4.526400E-01 |
| Stage1-vs-Stage4 |
2.715400E-01 |
| Stage2-vs-Stage3 |
3.545600E-01 |
| Stage2-vs-Stage4 |
3.026200E-01 |
| Stage3-vs-Stage4 |
8.150800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.400200E-01 |
| Normal-vs-AfricanAmerican |
5.766800E-04 |
| Normal-vs-Asian |
7.337400E-01 |
| Caucasian-vs-AfricanAmerican |
1.9521999999883E-06 |
| Caucasian-vs-Asian |
9.724800E-01 |
| AfricanAmerican-vs-Asian |
4.694000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.691200E-01 |
| Normal-vs-Female |
6.487400E-01 |
| Male-vs-Female |
7.298400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.025810E-01 |
| Normal-vs-Age(41-60Yrs) |
5.786800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.605400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.510400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.369790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.532380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.289400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.743600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.565400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.398000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.924200E-01 |
| Normal-vs-Grade 2 |
2.254400E-01 |
| Normal-vs-Grade 3 |
9.656200E-01 |
| Normal-vs-Grade 4 |
1.121210E-01 |
| Grade 1-vs-Grade 2 |
9.150000E-01 |
| Grade 1-vs-Grade 3 |
4.634400E-01 |
| Grade 1-vs-Grade 4 |
1.158370E-01 |
| Grade 2-vs-Grade 3 |
1.626230E-01 |
| Grade 2-vs-Grade 4 |
7.079600E-03 |
| Grade 3-vs-Grade 4 |
9.991700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.098170E-02 |
| Normal-vs-ccB subtype |
6.207800E-01 |
| ccA subtype-vs-ccB subtype |
2.840300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.909600E-01 |
| Normal-vs-N1 |
9.131200E-01 |
| N0-vs-N1 |
7.207400E-01 |
|
|
